CD4 and neoplasm: We then assessed by flow cytometry activation markers associated with effector function (CD69, CD44 and 2-NDGB) expressed on tumor infiltrating CD4+ and CD8+ T cells from anti-PD-1 (Figure 2F) and anti-PD-L1 (Figure 2G) refractory mice.